Simponi (golimumab) 50mg and 100mg - Important Safety Information from Janssen Biologics B.V. and Merck Sharp & Dohme Ireland (Human Health) Ltd as approved by the HPRA (09.08.23)

Notice type: 3rd Party Publications

Date: 09/08/2023

Important Safety Information from Janssen Biologics B.V. and Merck Sharp & Dohme Ireland (Human Health) Ltd regarding Simponi (golimumab) 50mg and 100mg: Important changes to the injection instructions for the SmartJect Pre-filled Pen